AG-01（A&G Pharm）

N/A

Report date: 2022/12/08 20:00:49

Base Information

Drug NameAG-01（A&G Pharm）
Drug Alias NameAG-01（A&G Pharm）
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProgranulin modulators
TargetsProgranulin
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungTriple Negative Breast NeoplasmsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesA&G Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesA&G Pharmaceutical
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungTriple Negative Breast NeoplasmsMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A